Loading clinical trials...
Loading clinical trials...
The Effects of Treatment Guided by Cerebral Oximetry Monitoring on Renal Outcomes in Invasively Mechanically Ventilated Neonates: an Ancillary Study of the SafeBoosC-IIIv Trial
Cerebral oximetry monitoring allows clinicians to optimize blood flow to the brain and oxygenation using the SafeBoosC treatment guideline. The guideline's interventions aims to stabilize blood pressure and oxygen levels. As low blood pressure is a risk factor for the development of kidney injury, normalizing blood pressure may decrease the incidence of kidney injury in new-borns who are on ventilator.
Age
0 - 0 years
Sex
ALL
Healthy Volunteers
No
St. jOhn's Medical college & Hospital
Bengaluru, Karnataka, India
Start Date
July 31, 2025
Primary Completion Date
June 1, 2027
Completion Date
September 15, 2027
Last Updated
July 23, 2025
1,000
ESTIMATED participants
Intervention Arm- Cerebral Oximetry + Treatment Guideline
OTHER
Lead Sponsor
St. John's Research Institute
Collaborators
NCT04334707
NCT01682590
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions